![]() |
|
|
Forward to a colleague |
||
Access Full Stories Researchers at the Broad Institute of MIT and Harvard, USA, have successfully employed a new technique developed by Agilent that could potentially eliminate one of the biggest bottlenecks in the genetic sequencing... Read Sigma-Aldrich smashes $2bn mark in 2007 sales Sigma-Aldrich has reported record annual revenues of $2.04bn in 2007, fuelled by strong growth in life science products and fine chemicals, favourable exchange rates and a $60m acquisition... Read Quotient bolsters its drug development services Quotient BioResearch, a European analytical and safety evaluation services firm, has bolstered its business with the acquisition of BioDynamics Research... Read EC 'unlikely to support ban on primate testing' The European Commission is unlikely to support an outright ban on the use of non-human primates in research, but has just published a new document which indicates that significant changes to current legislation... Read Single molecule sensor could advance on lab-on-a-chip tech For the first time, US scientists have found a way of simultaneously performing optical and electrical measurements on the same single molecule, which could pave the way for mass produced single molecule sensors... Read |
|||||||||||||||||
All News Headlines for: February | January | December |
|||||||||||||||||
|
Related Industry News China plant implicated in heparin scare Questions are hanging over the role of a Chinese manufacturing facility in the Baxter heparin scare after it has emerged that the US Food and Drug Administration (FDA) has never inspected the facility... Read Polyplus gene delivery tool poised for Phase II A Phase II clinical trial using French company Polyplus-transfection's innovative gene delivery tool, in vivo-jetPEI, is set to go ahead this month in Europe and the US... Read Pfizer expands in inhaled drugs as Nektar cuts back Pfizer's announcement of plans to create a new €130m inhaled medicines unit at its facility in Amboise, France suggests that the firm is still intent on investing in inhalation technology, despite its disappointment... Read Baxter suspends production of heparin after deaths Baxter International has suspended the production of its blood-thinning drug heparin in multi-dose vials, following the deaths of four patients in the USA who were given the drug in high doses... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||